KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Dec 11, 2023 Buy 10 000 Lockshin Curtis Stock Options
Dec 11, 2023 Buy 20 000 Eisenberg Jeffrey F Stock Options
Dec 11, 2023 Buy 10 000 Parslow James F Stock Options
Dec 06, 2023 Buy 2 500 Mizrahy Moshe Stock Options
Dec 06, 2023 Buy 0 Mizrahy Moshe Common Stock
Dec 06, 2023 Buy 2 500 Kornberg Roger D. Stock Options
Dec 06, 2023 Buy 2 500 Borisenko Grigory G. Stock Options
Dec 06, 2023 Buy 2 500 Dastoor Firdaus J. Stock Options
Dec 06, 2023 Buy 2 500 Callaway James Eric Stock Options
Dec 06, 2023 Buy 2 500 Vinogradov Alexey Andreevich Stock Options
Dec 06, 2023 Buy 2 500 Logal Adam Stock Options
Dec 07, 2022 Buy 25 000 Vinogradov Alexey Andreevich Stock Options
Dec 07, 2022 Buy 25 000 Logal Adam Stock Options
Dec 07, 2022 Buy 25 000 Kornberg Roger D. Stock Options
Dec 07, 2022 Buy 25 000 Dastoor Firdaus J. Stock Options
Dec 07, 2022 Buy 25 000 Callaway James Eric Stock Options
Dec 07, 2022 Buy 25 000 Borisenko Grigory G. Stock Options
Mar 24, 2022 Buy 100 000 Eisenberg Jeffrey F Stock Options
Mar 24, 2022 Buy 100 000 Eisenberg Jeffrey F Stock Options
Mar 24, 2022 Buy 50 000 Parslow James F Stock Options
Mar 24, 2022 Buy 50 000 Parslow James F Stock Options
Mar 24, 2022 Buy 50 000 Lockshin Curtis Stock Options
Mar 24, 2022 Buy 50 000 Lockshin Curtis Stock Options
Dec 07, 2021 Buy 25 000 Logal Adam Stock Options
Dec 07, 2021 Buy 25 000 Logal Adam Stock Options
Dec 07, 2021 Buy 25 000 Vinogradov Alexey Andreevich Stock Options
Dec 07, 2021 Buy 25 000 Kornberg Roger D. Stock Options
Dec 07, 2021 Buy 25 000 Kornberg Roger D. Stock Options
Dec 07, 2021 Buy 25 000 Dastoor Firdaus J. Stock Options
Dec 07, 2021 Buy 25 000 Callaway James Eric Stock Options
Mar 18, 2021 Buy 50 000 Parslow James F Stock Options
Mar 18, 2021 Buy 50 000 Parslow James F Stock Options
Mar 18, 2021 Buy 100 000 Eisenberg Jeffrey F Stock Options
Mar 18, 2021 Buy 100 000 Eisenberg Jeffrey F Stock Options
Mar 18, 2021 Buy 50 000 Lockshin Curtis Stock Options
Mar 18, 2021 Buy 50 000 Lockshin Curtis Stock Options
Dec 04, 2020 Buy 25 000 Vinogradov Alexey Andreevich Stock Options
Dec 04, 2020 Buy 25 000 Logal Adam Stock Options
Dec 04, 2020 Buy 25 000 Logal Adam Stock Options
Dec 04, 2020 Buy 25 000 Kornberg Roger D. Stock Options
Dec 04, 2020 Buy 25 000 Kornberg Roger D. Stock Options
Dec 04, 2020 Buy 25 000 Dastoor Firdaus J. Stock Options
Dec 04, 2020 Buy 25 000 Callaway James Eric Stock Options
Dec 04, 2019 Buy 80 000 Parslow James F Stock Options
Dec 04, 2019 Buy 80 000 Parslow James F Stock Options
Dec 04, 2019 Buy 25 000 Logal Adam Stock Options
Dec 04, 2019 Buy 25 000 Logal Adam Stock Options
Dec 04, 2019 Buy 90 000 Lockshin Curtis Stock Options
Dec 04, 2019 Buy 90 000 Lockshin Curtis Stock Options
Dec 04, 2019 Buy 25 000 Kornberg Roger D. Stock Options
Dec 04, 2019 Buy 25 000 Kornberg Roger D. Stock Options
Dec 04, 2019 Buy 230 000 Eisenberg Jeffrey F Stock Options
Dec 04, 2019 Buy 230 000 Eisenberg Jeffrey F Stock Options
Dec 04, 2019 Buy 25 000 Dastoor Firdaus J. Stock Options
Dec 04, 2019 Buy 25 000 Callaway James Eric Stock Options
Sep 26, 2019 Buy 0 Borisenko Grigory G.
Sep 26, 2019 Buy 25 000 Vinogradov Alexey Andreevich Stock Options
Sep 26, 2019 Buy 25 000 Borisenko Grigory G. Stock Options
Sep 26, 2019 Buy 0 Borisenko Grigory G.
Jul 19, 2019 Buy 0 Vinogradov Alexey Andreevich Common Stock
Jul 19, 2019 Buy 93 390 Genkin Dmitry Common Stock
Nov 28, 2018 Buy 25 000 Callaway James Eric Stock Options
Nov 28, 2018 Buy 25 000 Dastoor Firdaus J. Stock Options
Nov 28, 2018 Buy 25 000 Logal Adam Stock Options
Nov 28, 2018 Buy 25 000 Logal Adam Stock Options
Nov 28, 2018 Buy 25 000 Kornberg Roger D. Stock Options
Nov 28, 2018 Buy 25 000 Kornberg Roger D. Stock Options
Mar 14, 2018 Sell 29 452 Genkin Dmitry Common Stock
Nov 15, 2017 Buy 25 000 Dastoor Firdaus J. Stock Option
Nov 15, 2017 Buy 25 000 Kornberg Roger D. Stock Option
Nov 15, 2017 Buy 25 000 Kornberg Roger D. Stock Option
Oct 26, 2017 Buy 250 000 Eisenberg Jeffrey F Stock Options
Oct 26, 2017 Buy 250 000 Eisenberg Jeffrey F Stock Options
Oct 26, 2017 Buy 50 000 Eisenberg Jeffrey F Common Stock
Oct 26, 2017 Buy 50 000 Eisenberg Jeffrey F Common Stock
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Logal Adam Stock Option
Oct 11, 2017 Buy 6 250 Callaway James Eric Stock Option
Oct 11, 2017 Buy 6 250 Callaway James Eric Stock Option
Oct 11, 2017 Buy 6 250 Callaway James Eric Stock Option
Oct 11, 2017 Buy 6 250 Callaway James Eric Stock Option
Aug 14, 2017 Buy 0 Genkin Dmitry Common Stock
Nov 07, 2016 Buy 1 454 545 Pjsc Pharmsynthez Class B Warrants
Sep 09, 2016 Buy 32 526 Pjsc Pharmsynthez Warrants
Jul 01, 2016 Buy 50 506 Pjsc Pharmsynthez Warrants
Sep 06, 2015 Buy 37 879 Genkin Dmitry Stock Options
Dec 31, 2014 Buy 204 394 Llc Synbio Warrants
Dec 31, 2014 Buy 204 394 Pjsc Pharmsynthez Warrants
Jan 23, 2014 Buy 0 Llc Synbio Series A Preferred Stock
Jan 23, 2014 Buy 0 Llc Synbio Common Stock
Jan 23, 2014 Buy 0 Pjsc Pharmsynthez Common Stock
Jan 23, 2014 Buy 0 Pjsc Pharmsynthez Series B Preferred Stock
Jan 23, 2014 Buy 0 Pjsc Pharmsynthez Series A Preferred Stock
Jan 23, 2014 Buy 0 Pjsc Pharmsynthez Common Stock
INSIDER POWER
81.367
Last 100 transactions
Buy: 5 335 134 | Sell: 29 452 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 81.367.

In total, the insiders bought 5 335 134 and sold 29 452 XBIO shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Xenetic Biosciences Inc

Xenetic Biosciences Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor ... XBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT